Retrospective case-control study of adult patients with SISNHL from 2005 through 2009 treated with intratympanic dexamethasone alone or in combination with oral prednisone taper and/or oral L-NAC. Interventions were medical history, physical examination, and audiometry. Main outcome measure was initial-to-final change of pure-tone average of two sets of 3-frequencies: low (0.5, 1 and 2 kHz) and high (2, 4 and 8 kHz). Hearing recovery was defined as an improvement of at least 50% of initial-to-final difference and was compared between those who received L-NAC and those who did not, using Fisher's exact test. We tested the influence of demographic, clinical and treatment variables on hearing recovery using a regression analysis. RESULTS: 44% of all patients had hearing recovery at both low and high frequencies; mean hearing improvement was 15.4 dB (SD, 18 dB) for low frequencies and 12.7 dB (SD, 16 dB) for high frequencies.
Magnetic Resonance Imaging of Stem Cells in the Cochlea
Michael Fritsch, MD (presenter); Akihiro Matsuoka, MD, PhD; Eri Hashino, PhD OBJECTIVE: MRI is the only currently available imaging modality that allows non-invasive and repeated monitoring of stem cells in human patients. The objectives of this study were to: 1) Test the feasibility of MnCl2 as a novel MRI contrast agent to visualize stem cell engraftment in the human cochlea. 2) Determine imaging parameters that provide the maximum contrast between donor stem cells and recipient cochlear structures. METHOD: Human cadaver temporal bones were placed in the center of a Varian 9.4 T actively shielded horizontal bore MR system. Pre-transplantation scanning was performed and Axial T1-weighted images were acquired using a 3D asymmetric spin-echo pulse sequence. Serial MRI sections at 200 m intervals were obtained throughout the modiolar axis of the cochlea. After the initial scan, MnCl2-labeled mouse embryonic stem cells were injected through the middle turn of the cochlea, and post-transplantation images were obtained using the same imaging parameters. RESULTS: MnCl2 is a strong T1 relaxation agent which when imaged with T1 sensitive sequences produces significant hyperintensity of the labeled cells. Regions in post-transplantation cochleae exhibited hyperintense contrasts when compared to pre-transplantation cochleae. In addition, the surrounding non-labeled structure of the modiolus, spiral ganglion and organ of Corti appeared hypointense relative to labeled cells. CONCLUSION: We successfully established an MRI procedure to visualize transplanted stem cells in the cochlea. MnCl2 generates local hyperintense contrasts, which is less likely to be confused with intrinsic hypointense contrasts and may serve as a superior contrast agent to iron oxide particles.
Management of Spontaneous CSF Leaks of Temporal Bone
Sepehr Oliaei, MD (presenter); Hamid Djalilian, MD OBJECTIVE: To evaluate the various presentations and different treatment options for spontaneous cerebrospinal fluid (CSF) leakage originating in the temporal bone. METHOD: Retrospective review of medical records at a tertiary medical center was performed. Thirteen patients diagnosed with spontaneous CSF leakage over a 7-year period were included in the study. The age ranged between 57 and 84. Presenting symptoms included serous otitis media (54%), persistent otorrhea after tympanostomy tube placement (23%), and meningitis (23%). Pre-operative diagnosis was made using imaging studies. Treatment was Eustachian tube plugging (8%), mastoidectomy with obliteration with fat (46%), or middle fossa approach with extradural (36%), or intradural (9%) repair. RESULTS: Successful treatment was obtained in 12 of the 13 patients undergoing repair of the dehiscent tegmen. The only failure was a patient with a posterior fossa source for the leakage with a high flow leak. Pathologic confirmation of the existence of brain and aggressive arachnoid granulation in the mastoid was obtained in some patients. CONCLUSION: Diagnosis of spontaneous CSF leakage from the temporal bone is complex given beta-2-transferrin testing is not reliable due to the scant amount of fluid available. CT and MR imaging are the keys to the diagnosis. This disease is probably more common than previously thought. The treatment of the disorder must be tailored to the patients age, medical status, and the extent of tegmen dehiscence.
Minocycline May Weaken Ototoxicity
Du Bo, MD, PhD (presenter); Wang Ping, PhD OBJECTIVE: Some agents have been found that would prevent cisplatin-induced ototoxicity. However, it cannot be ignored with the antitumor activity from a clinical perspective. In this report, we focus on minocycline, which would protect the cochlea against cisplatin damage, prevent hearing loss, and enhance the cytotoxicity of anticancer therapies.
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